News
May 6, 2025

Regenstrief Institute researchers to present at AGS 2025 annual scientific meeting

AGS 2025 Conference image

Regenstrief staffers Alex Floyd and Anna Higbie at the Center for Aging Research's booth at the 2025 American Geriatrics Society meeting. Researchers from the IU Center for Aging Research at Regenstrief Institute will join national experts May 8-10, 2025, in Chicago at the American Geriatrics Society (AGS) 2025 Annual Scientific Meeting to present new findings aimed at improving care for older adults. 

The AGS Annual Scientific Meeting is the premier educational event in geriatrics, offering state-of-the-art sessions on clinical care, aging research, health policy and innovative care models. Attendees include physicians, nurses, pharmacists, physician associates, social workers and other professionals dedicated to advancing care for aging populations. 

Malaz Boustani speaks as part of a panel at the 2025 American Geriatrics Society meeting.Malaz A. Boustani, M.D., MPH, a research scientist at Regenstrief, will participate in three presentations: 

  • “Creating the Demand for AGS CoCare: HELP” – This session will highlight strategies to expand the implementation of evidence-based programs to prevent delirium in hospitalized older adults. 
  • “Dementia Care Reimagined: Practical Strategies for Better Outcomes” – Dr. Boustani will present findings from the Dementia Digital Detection (D3) Trial in Indiana, which focuses on innovative digital tools to improve early detection of cognitive impairment. 
  • “Inspiring and Sustaining an Aging Research Career Through the Ups and Downs of Life” – As a panelist in this research-focused session, Dr. Boustani will join a multigenerational group of researchers to share insights on resilience and career sustainability in aging research.  

Malaz Boustani speaks at the 2025 American Geriatrics Society meeting.Additionally, Kathleen Unroe, M.D., MHA, M.S., a research scientist at Regenstrief and principal investigator of the NEXT STEPs initiative, will moderate a panel at the symposium. 

  • “Nursing Home Transformation: Building a Research Agenda and Clinical Trials Infrastructure.” This session will discuss the $15.6 million NIA-funded NEXT STEPs program, which aims to build a diverse network of nursing home partners and researchers conducting clinical trials to improve care. 

In addition to these presentations, Regenstrief researchers will participate in workshops, symposia and networking events, contributing to national conversations on transforming geriatrics care and research. 

Malaz Boustani, M.D., MPH
In addition to his role as a research scientist with the Indiana University Center for Aging Research at Regenstrief Institute, Malaz Boustani, M.D., MPH, is the founding director of the Center for Health Innovation and Implementation Science. He is a professor and the Richard M. Fairbanks Chair of Aging Research at the Indiana University School of Medicine. Dr. Boustani is also director of care innovation at Eskenazi Health. 

Kathleen Unroe, M.D., MHA
In addition to being a research scientist with the Indiana University Center for Aging Research at Regenstrief Institute, Kathleen Unroe, M.D., MHA, is a professor of medicine at Indiana University School of Medicine and a practicing geriatrician. 

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time